
ProShares Russell 2000 High Income ETF
ProShares Russell 2000 High Income ETF (ITWO) Price & Chart
ITWO ETF Chart & Stats
- Day’s Range
- $42.13 - $42.59
- 52-Week Range
- $37.09 - $47.19
- Previous Close
- $42.73
- Volume
- 17.64K
- Average Volume (3M)
- 22.65K
- AUM
- 176.82M
- NAV
- 42.48
- Expense Ratio
- 0.55%
- Holdings Count
- 1,958
- Beta
- 0.93
- Inception Date
- Sep 04, 2024
- Last Dividend Ex-Date
- Nov 02, 2026
- Dividend Yield
- (7.84%)
- Shares Outstanding
- 4,150,000
- Standard Deviation
- N/A
ETF Overview
ProShares Russell 2000 High Income ETF
The ProShares Russell 2000 High Income ETF (Ticker: ITWO) is a compelling investment vehicle tailored for those seeking exposure to the dynamic and high-potential segment of small-cap companies within the U.S. equity market. This ETF is firmly rooted in the Size and Style category, with a precise focus on small-cap stocks, making it an ideal choice for investors aiming to diversify their portfolios with high-growth potential assets. ITWO uniquely carves out its niche by concentrating on small-cap companies that offer robust dividend yields, providing an attractive blend of growth and income. By tracking the Russell 2000 High Dividend Index, the fund encompasses a broad-based array of small-cap firms, ensuring diversified exposure across various sectors. This strategic selection is designed to capitalize on the agility and entrepreneurial spirit of smaller companies, while also benefiting from their capacity to deliver substantial income through dividends. Investors looking to enhance their portfolio's return through high-income generation, coupled with the upside potential characteristic of small-cap equities, will find ITWO an engaging addition. The fund not only offers a tactical exposure to the small-cap segment but also strategically emphasizes income, making it an intriguing choice for those balancing growth and yield in their investment strategy.
- Asset Class
- Equity
- Region
- North America
- Issuer
- ProShares
- Index Tracked
- Cboe Russell 2000 Daily Covered Call Index - Benchmark TR Gross
- Ticker Symbol
- ITWO
ITWO ETF News


Vaxcyte, Inc. ($PCVX) announced an update on their ongoing clinical study. Study Overview: The official title is A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability,

Vaxcyte, Inc. ($PCVX) announced an update on their ongoing clinical study. Study Overview: Vaxcyte’s Phase 3 study, officially titled “A Phase 3, Randomized, Double-Blind, Active-Controlled Clinical Study to Evaluate the
ITWO ETF FAQ
What was ITWO’s price range in the past 12 months?
What is the AUM of ITWO?
Is ITWO overvalued?
Does ITWO pay dividends?
How many shares outstanding does ITWO have?
ITWO ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| GKOSGlaukos Corp. | 0.45% |
| FROGJfrog Ltd. | 0.39% |
| BTSGBrightSpring Health Services, Inc. | 0.38% |
| UMBFUmb Financial Corp. | 0.31% |
| MOG.AMoog Inc. | 0.31% |
| TGTXTG Therapeutics | 0.30% |
| JXNJackson Financial Incorporation Class A | 0.29% |
| RHPRyman Hospitality Properties | 0.29% |
| CTRECareTrust REIT | 0.29% |
| PCVXVaxcyte, Inc. | 0.28% |
| Total | 3.29% |












